Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Sims

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
JAMA Neurology|October 17, 2022
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical TrialMichael J Pontecorvo, Ming Lu, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Donanemab exposure-response in early symptomatic Alzheimer's diseaseIvelina Gueorguieva, Kay Chow, Laiyi Chua, et al.
Critical Care Medicine|October 25, 2011
Clinical examination for outcome prediction in nontraumatic comaDavid M Greer, Jingyun Yang, Patricia D Scripko, et al.
The Laryngoscope|December 31, 2019
Reconstructive and prosthodontic outcomes after multiple palatomaxillary reconstructionsKayvon F Sharif, John R Sims, Lauren E Yue, et al.
Surgical Oncology|March 19, 2018
Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patientsJohn R Sims, Travis E Grotz, Barbara A Pockaj, et al.
Stem Cells (Dayton, Ohio)|April 9, 2009
p27Kip1 constrains proliferation of neural progenitor cells in adult brain under homeostatic and ischemic conditionsJianhua Qiu, Yasushi Takagi, Jun Harada, et al.
Head & Neck|May 7, 2019
A novel approach to neurologic function sparing surgical management of vagal schwannomas: Continuous intraoperative nerve monitoring of the laryngeal adductor reflexMykayla L Sandler, John R Sims, Catherine Sinclair, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
JAMA Neurology|October 13, 2025
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical TrialMing Lu, Min Jung Kim, Emily C Collins, et al.
Neurology|February 22, 2024
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer DiseaseAdam S Fleisher, Leanne M Munsie, David G S Perahia, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
JAMA Neurology|October 17, 2022
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical TrialMichael J Pontecorvo, Ming Lu, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Donanemab exposure-response in early symptomatic Alzheimer's diseaseIvelina Gueorguieva, Kay Chow, Laiyi Chua, et al.
Critical Care Medicine|October 25, 2011
Clinical examination for outcome prediction in nontraumatic comaDavid M Greer, Jingyun Yang, Patricia D Scripko, et al.
The Laryngoscope|December 31, 2019
Reconstructive and prosthodontic outcomes after multiple palatomaxillary reconstructionsKayvon F Sharif, John R Sims, Lauren E Yue, et al.
Surgical Oncology|March 19, 2018
Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patientsJohn R Sims, Travis E Grotz, Barbara A Pockaj, et al.
Stem Cells (Dayton, Ohio)|April 9, 2009
p27Kip1 constrains proliferation of neural progenitor cells in adult brain under homeostatic and ischemic conditionsJianhua Qiu, Yasushi Takagi, Jun Harada, et al.
Head & Neck|May 7, 2019
A novel approach to neurologic function sparing surgical management of vagal schwannomas: Continuous intraoperative nerve monitoring of the laryngeal adductor reflexMykayla L Sandler, John R Sims, Catherine Sinclair, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
JAMA Neurology|October 13, 2025
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical TrialMing Lu, Min Jung Kim, Emily C Collins, et al.
Neurology|February 22, 2024
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer DiseaseAdam S Fleisher, Leanne M Munsie, David G S Perahia, et al.
Pageof 10